cached image

Andrew P. Lieberman, MD PhD - US grants

Affiliations: 
Pathology University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Mechanisms of neurodegeneration in Kennedy's Disease.
Website:
http://www.pathology.med.umich.edu/faculty/Lieberman,A/index.html

We are testing a new system for linking grants to scientists.

The funding information displayed below comes from the NIH Research Portfolio Online Reporting Tools and the NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please sign in and mark grants as correct or incorrect matches.

Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.

High-probability grants

According to our matching algorithm, Andrew P. Lieberman is the likely recipient of the following grants.
Years Recipients Code Title / Keywords Matching
score
2002 — 2003 Lieberman, Andrew P
K02Activity Code Description:
Undocumented code - click on the grant title for more information.

Altered Androgen Receptor Function Due to Cag Expansion

@ University of Michigan At Ann Arbor

1
2004 — 2006 Lieberman, Andrew P
K08Activity Code Description:
To provide the opportunity for promising medical scientists with demonstrated aptitude to develop into independent investigators, or for faculty members to pursue research aspects of categorical areas applicable to the awarding unit, and aid in filling the academic faculty gap in these shortage areas within health profession's institutions of the country.

Modifiers of Polyglutamine Toxicity

@ University of Michigan At Ann Arbor

1
2005 — 2009 Lieberman, Andrew P
P50Activity Code Description:
To support any part of the full range of research and development from very basic to clinical; may involve ancillary supportive activities such as protracted patient care necessary to the primary research or R&D effort. The spectrum of activities comprises a multidisciplinary attack on a specific disease entity or biomedical problem area. These grants differ from program project grants in that they are usually developed in response to an announcement of the programmatic needs of an Institute or Division and subsequently receive continuous attention from its staff. Centers may also serve as regional or national resources for special research purposes.

Core--Neuropathology Core

@ University of Michigan At Ann Arbor

1
2007 — 2008 Lieberman, Andrew P
R03Activity Code Description:
To provide research support specifically limited in time and amount for studies in categorical program areas. Small grants provide flexibility for initiating studies which are generally for preliminary short-term projects and are non-renewable.

A Conditional Null Mutant of the Mouse Npc1 Gene

@ University of Michigan At Ann Arbor

1
2007 — 2020 Lieberman, Andrew P
R01Activity Code Description:
To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies.

Mechanisms of Motor Neuron Toxicity in Kennedy Disease

@ University of Michigan

1
2009 — 2019 Lieberman, Andrew P
R01Activity Code Description:
To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies.

Unraveling Mechanisms of Niemann-Pick C Neuropathology With Mouse Models

@ University of Michigan

1
2012 — 2013 Lieberman, Andrew P
R21Activity Code Description:
To encourage the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.)

Targeting Proteostasis to Treat Niemann-Pick C Disease

@ University of Michigan

1
2013 — 2014 Lieberman, Andrew P
R03Activity Code Description:
To provide research support specifically limited in time and amount for studies in categorical program areas. Small grants provide flexibility for initiating studies which are generally for preliminary short-term projects and are non-renewable.

Androgen Receptor Sumoylation in Sbma

@ University of Michigan

1
2014 — 2015 Lieberman, Andrew P
R21Activity Code Description:
To encourage the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.)

Antisense Oligonucleotides to Treat Spinal and Bulbar Muscular Atrophy

@ University of Michigan

1
2016 — 2019 Lieberman, Andrew P
P30Activity Code Description:
To support shared resources and facilities for categorical research by a number of investigators from different disciplines who provide a multidisciplinary approach to a joint research effort or from the same discipline who focus on a common research problem. The core grant is integrated with the center's component projects or program projects, though funded independently from them. This support, by providing more accessible resources, is expected to assure a greater productivity than from the separate projects and program projects.

Core D: Neuropathology Core

@ University of Michigan

1
2016 — 2019 Lieberman, Andrew P
Nikolovska-Coleska, Zaneta
T32Activity Code Description:
To enable institutions to make National Research Service Awards to individuals selected by them for predoctoral and postdoctoral research training in specified shortage areas.

Training Program in Translational Research

@ University of Michigan

1
2018 — 2020 Lieberman, Andrew P
Osawa, Yoichi (co-PI) [⬀]
R21Activity Code Description:
To encourage the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.)
R33Activity Code Description:
The R33 award is to provide a second phase for the support for innovative exploratory and development research activities initiated under the R21 mechanism. Although only R21 awardees are generally eligible to apply for R33 support, specific program initiatives may establish eligibility criteria under which applications could be accepted from applicants demonstrating progress equivalent to that expected under R33.

Small Molecule Stabilizers of Hsp70 For Treatment of Spinal and Bulbar Muscular Atrophy

@ University of Michigan

1